Effect of Semecarpus anacardium nut extract on ECM and proteases in mammary carcinoma rats

Vascular Pharmacology

Volumn 46, Issue 6, 2007, Pages 419-426

  Mathivadhani, P ^a   Shanthi, P ^a   Sachdanandam, P ^a  

^a Dr ALM Postgraduate Institute of Basic Medical Sciences   (India)

Author keywords

Breast cancer; ECM degradation; Proteases; Semecarpus anacardium

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; GELATINASE A; GLYCOSIDASE; INTERSTITIAL COLLAGENASE; PROTEINASE; SEMECARPUS ANACARDIUM EXTRACT; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CARCINOMA; CANCER CELL; CANCER GROWTH; CANCER INVASION; CANCER TISSUE; CELL MIGRATION; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM; ENZYME ACTIVITY; EPITHELIUM; EXTRACELLULAR MATRIX; FEMALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SEMECARPUS; TISSUE METABOLISM;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ADMINISTRATION, ORAL; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; EXTRACELLULAR MATRIX; FEMALE; GLYCOSIDE HYDROLASES; MAMMARY NEOPLASMS, EXPERIMENTAL; MATRIX METALLOPROTEINASES, SECRETED; NEOPLASM INVASIVENESS; NUTS; PEPTIDE HYDROLASES; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; SEMECARPUS; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 34047268322     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2006.12.004     Document Type: Article

References (63)

1. Alexander S.A., and Donoff R.B. The glycosaminoglycans of open wounds. J. Surg. Res. 29 (1980) 422-429
2. Anderson A.J. Effects of lysosomal collagenolytic enzymes, anti-inflammatory drugs and other substances on some properties of insoluble collagen. Biochem. J. 113 (1969) 457-463
3. Barrett A.J. A new assay for cathepsin B1 and other thiol proteinases. Anal. Biochem. 47 (1972) 280-293
4. Bendeck M.P., Keeley F.W., and Langille B.L. Perinatal accumulation of arterial wall constituents: relation to hemodynamic changes at birth. Am. J. Physiol. 267 (1994) 112268-112279
5. Bouchet, Hacène K., Martin P.M., Becette V., Tubiana-Hulin M., Lasry S., Oglobine J., and Spyratos F. Dissemination risk index based on plasminogen activator system components in primary breast cancer. J. Clin. Oncol. 17 (1999) 3048-3057
6. Breen M., Knepper P.A., Weinstein H.G., Blacik L.J., Lewandowski D.G., and Brdtrus B.M. Microanalysis of glycosaminoglycans. Anal. Biochem. 113 (1981) 416-422
7. Burleigh M.C., Barrett A.J., and Lazurus G.S. A lysosomal enzyme that degrades native collagen. Biochem. J. 137 (1974) 387-398
8. Carey D.J. Use of specific inhibitors of proteoglycan synthesis. Mol. Cell. Biochem. 104 (1991) 21-28
9. Chitinis M.P., Bhatia K.G., Phatak M.K., and Kesava Roa K.V. Antitumour activity of the extract of Semecarpus anacardium L. nuts in experimental tumour models. Indian J. Exp. Biol. 18 (1980) 6-8
10. Chonchie J., Gelman A.L., and Levvy G.A. Inhibition of glycosidases by aldonolactones of corresponding configuration. The C-4 and C-6 specificity of β-galactosidase. Biochem. J. 103 (1967) 609-615
11. Clauss M., Sunderkötter C., Sveinbjörnsson B., Hippenstiel S., Willuweit A., Marino M., Haas E., Seljelid R., Scheurich P., Suttorp N., Grell M., and Risau Hemostasis W. Thrombosis, and vascular biology - a permissive role for tumor necrosis factor in vascular endothelial growth factor-induced vascular permeability. Blood 97 (2001) 1321-1329
12. Cushman D.W., and Cheung H.S. Concentrations of angiotensin-converting enzyme in tissues of the rat. Biochim. Biophys. Acta 250 (1971) 261-265
13. Danilewiczcdef M., Sikorskabdfg B., and W1a{ogonek}growska-Danilewiczacdefg M. Prognostic significance of the immunoexpression of matrix metalloproteinase MMP2 and its inhibitor TIMP2 in laryngeal cancer. Med. Sci. Monit. 9 (2003) MT42-MT47
14. David H. Vegetables, fruits and phytoestrogens in the prevention of diseases. J. Postgrad. Med. 50 (2004) 145-149
15. DeClerck Y.A., Mercurio A.M., Stack M.S., Chapman H.A., Zutter M.M., Muschel R.J., Raz A., Matrisian L.M., Sloane B.F., Noel A., Hendrix M.J., Coussens L., and Padarathsingh M. Proteases, extracellular matrix, and cancer: a workshop of the path B study section. Am. J. Pathol. 164 (2004) 1141-1142
16. Dickson S.R., and Warburton M.J. Enhanced synthesis of gelatinase and stromelysin by myoepithelial cells during involution of the rat mammary gland. J. Histochem. Cytochem. 40 (1992) 5697-5703
17. Djonov J., Cresto N., Aebersold D.M., Burri P.H., Altermatt H.J., Hristic M., Berclaz G., Ziemieckiand A., and Andres A. Tumor cell specific expression of MMP-2 correlates with tumor vascularisation in breast cancer. Int. J. Oncol. 21 (2002) 25-30
18. Elson L.A., and Morgon W.T.J. A colorimetric method for the determination of glucosamine and chondrosamine. Biochem. J. 27 (1933) 1824-1828
19. Engbring J.A., and Kleinman H.K. The basement membrane matrix in malignancy. J. Pathol. 200 (2003) 465-470
20. Etherington D.J. The nature of the collagenolytic cathepsin of rat liver and its distribution in other rat tissues. Biochem. J. 127 (1972) 685-692
21. Fishman W.H., Kato K., Anstiss C.L., and Greens S. Human serum-glucuronidase: its measurement and some of its properties. Clin. Chim. Acta 15 (1967) 435-447
22. Formulary of Siddha Medicine, 1972. Published by Indian Medical Practitioners Co-operative Pharmacy and Stores Ltd., Chennai, IInd ed., pp 197.
23. Gilboa N., Erdman J., and Urizar R.E. Quantitative spectrophotometric assay of renal tissue plasminogen activator. Kidney Int. 22 (1982) 80S-83S
24. Giraudo E., Primo L., Audero E., Gerber H.P., Koolwijk P., Soker S., Klagsbrun M., Ferrara N., and Bussolino F. Tumor necrosis factor-α regulates expression of vascular endothelial growth factor receptor-2 and of its co-receptor neuropilin-1 in human vascular endothelial cells. J. Biol. Chem. 273 (1998) 22128-22135
25. Gomez D.E., Alonso D.F., Yoshiji H., and Thorgeirsson U.P. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur. J. Cell Biol. 74 (1997) 111-122
26. Havsteen B. Flavonoids, a class of natural products of high pharmacological potency. Biochem. Pharmacol. 32 (1983) 1141-1148
27. Hunt T.K., Conolly W.B., Aronson S.B., and Goldstein P. Anaerobic metabolism and wound healing: a hypothesis for the initiation and cessation of collagen synthesis in wounds. Am. J. Surg. 135 (1978) 328-332
28. Ingber D.E. Mechanical signaling and the cellular response to extracellular matrix in angiogenesis and cardiovascular physiology. Circ. Res. 15 (2002) 877-887
29. Itano N., Sawai T., Miyaishi O., and Kimata K. Relationship between hyaluronan production and metastatic potential of mouse mammary carcinoma cells. Cancer Res. 59 (1999) 2499-2504
30. Kim M.H. Flavonoids inhibit VEGF/bFGF-induced angiogenesis in vitro by inhibiting the matrix-degrading proteases. J. Cell. Biochem. 89 (2003) 529-538
31. Kirthikar K.R., and Basu B.D. Indian Medicinal Plants vol. I (1975), MS Bishon Singh-Mahendra Paul Singh Publishers, India
32. Lander A.D., and Selleck S.B. The elusive function of proteoglycans: in vivo veritas. J. Cell Biol. 148 (2000) 227-232
33. Mannello F. Natural bio-drugs as matrix metalloproteinase inhibitors: new perspectives on the horizon. Recent Patents on Anti-Cancer Drug Discovery vol. 1 (2006) 91-103
34. Mazzieri R., Masiero L., Zanetta L., Monea S., Onisto M., Garbisa S., and Mignatti P. Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants. EMBO J. 16 (1997) 2319-2332
35. Meier R.C., Derby E.L., Jick S.S., and Jick H. Angiotensin-converting enzyme inhibitors, calcium channel blockers, and breast cancer. Arch. Intern. Med. 160 (2000) 349-353
36. Moore J.C., and Morris J.E. A simple automated colorimetric method for determination of N-acetyl β-d-glucosaminidase. Ann. Clin. Biochem. 19 (1982) 157-159
37. Moranoa S., Cipriania R., Cerritob M.G., Santangeloa C., Vasaturob F., Pantellinia F., Sensia M., Guidobaldia L., Scarpab S., and Di Marioa U. Angiotensin-converting enzyme inhibition modulates high-glucose-induced extracellular matrix changes in mouse glomerular epithelial cells. Nephron: Exper. Nephrol. 95 (2003) e30-e35
38. Morgan H., and Hill P.A. Human breast cancer cell-mediated bone collagen degradation requires plasminogen activation and matrix metalloproteinase activity. Cancer Cell Int. 5 (2005) 1
39. Moscatelli D., and Rifkin D. Membrane and matrix localization of proteinases: a common theme in the cell invasion and angiogenesis. Biochim. Biophys. Acta 948 (1988) 67-85
40. Newman R.E., and Logan M.A. The determination of hydroxyproline. J. Biol. Chem. 184 (1950) 299-306
41. Nimmi M.E., and Harkness R.D. Molecular structure and function of collagen. In: Nimmi M.E. (Ed). Collagen, Vol I, Biochemistry (1988), Baca Raton, CRC Press 1-77
42. Paku S., and Paweletz N. First steps in tumor-related angiogenesis. Lab. Invest. 65 (1991) 334-346
43. Postlethwaite A.E., Seyer J.M., and Knag A.H. Chemotactic attraction of human fibroblasts to type I, II and III collagens and collagen-derived peptides. Proc. Natl. Acad. Sci. U. S. A. 75 (1978) 871-875
44. Premalatha B. Semecarpus anacardium Linn. nuts - a boon in alternative medicine. Indian J. Exp. Biol. 38 (2000) 1177-1182
45. Premalatha B., Sujatha V., and Sachdanandam P. Modulating effect of Semecarpus anacardium Linn. nut extract on glucose metabolizing enzymes in aflatoxin B1-induced experimental hepatocellular carcinoma. Pharmacol. Res. 36 (1997) 187-192
46. Ruoslahti E. Proteoglycans in cell regulation. J. Biol. Chem. 264 (1989) 13369-13372
47. Sandra V., Verstraeten S.V., Keen C.L., Schmitz H.H., Fraga C.G., and Oteiza P.I. Flavan-3-ols and procyanidins protect liposomes against lipid oxidation and disruption of the bilayer structure. Free Radic. Biol. Med. 34 (2003) 84-92
48. Sapolsky A.I., Altman R.D., and Howell D.S. Cathepsin D activity in normal and osteoarthritic human cartilage. Fed. Proc. 32 (1973) 1489-1493
49. Schiller S., Slover G.A., and Dorfman A. A method for the separation of acid mucopolysaccharides: its application to the isolation of heprin from the skin of rats. J. Biol. Chem. 236 (1961) 983-987
50. Shao Z.M., Wu J., Shen Z.Z., and Barsky S.H. Genistein exerts multiple suppressive effects on human breast carcinoma cells. Cancer Res. 58 (1998) 4851-4857
51. Smith R.L., Gilkerson E., Kohatsu N., Merchant T., and Schurman D.J. Quantitative microanalysis of synovial fluid and articular cartilage glycosaminoglycans. Anal. Biochem. 103 (1980) 191-200
52. Sujatha V., and Sachdanandam P. Effect of Semecarpus anacardium Linn nut extract on experimental mammary carcinoma in Sprague-Dawley rats with reference to tumour marker enzymes. Pharm. Pharmacol. Commun. 6 (1999) 375-379
53. Tixier J.M., Godeau G., Robert A.M., and Hornebeck W. Evidence by in vivo and in vitro studies that binding of pycnogenols to elastin affects its rate of degradation by elastases. Biochem. Pharmacol. 33 (1984) 3933-3939
54. Truppe W., and Kresse H. Uptake of proteoglycans and sulfated glycosaminoglycans by cultured skin fibroblasts. Eur. J. Biochem. 85 (1978) 351-356
55. Udapa S.L. Inhibition of lysyl oxidase by isonaiazid and its effect on wound healing. Indian J. Exp. Biol. 33 (1995) 278-280
56. Vad B.G. Study of complete regression in four cases of cancer. Indian Pract. 26 (1973) 253-262
57. Vijayalakshmi T., Muthulakshmi V., and Sachdanandam P. Effect of milk extract of Semecarpus anacardium nut on adjuvant arthritis - a dose dependent study in Wistar albino rats. Gen. Pharmacol. 27 (1996) 1223-1226
58. Welgus H.G., Campbell E.J., Par-Shavit Z., Senior R.M., and Teitelbaum S.L. Human alveolar macrophages produce a fibroblast-like collagenase and collagenase inhibitor. J. Clin. Invest. 76 (1985) 219-224
59. Welsch C.W. Factors affecting the growth of carcinogen induced rat mammary carcinomas. A review and tribute to Charles Brendon Huggins. Cancer Res. 45 (1985) 3415-3443
60. Williams B. A potential role for angiotensin II-induced vascular endothelial growth factor expression in the pathogenesis of diabetic nephropathy?. Miner. Electrolyte Metab. 24 (1998) 400-405
61. Woessner J.F. Catabolism of collagen and non-collagen protein in the rat uterus during post-partum involution. Biochem. J. 83 (1962) 304-314
62. Woessner J.F. Total, latent and active collagenase during the course of postpartum involution of the rat uterus. Biochem. J. 180 (1979) 95-102
63. Woessner J.F. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 5 (1991) 2145-2154